CIAM
NUVB icon

Caitong International Asset Management’s Nuvation Bio NUVB Stock Holding History

Caitong International Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4K Sell
932
-14,105
-94% -$78.6K ﹤0.01% 1159
2025
Q4 		$135K Sell
15,037
-24,913
-62% -$154K 0.03% 320
2025
Q3 		$148K Buy
39,950
+35,568
+812% +$96.9K 0.1% 110
2025
Q2 		$8.54K Buy
4,382
+4,380
+219,000% +$9.12K 0.01% 784
2025
Q1 		$4 Buy
+2
New +$5 ﹤0.01% 2098

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Caitong International Asset Management's NUVB Position: Q1 2026 in Review

Caitong International Asset Management reduced its Nuvation Bio (NUVB) stake by 94% in Q1 2026, selling an estimated $78.6K and leaving 932 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

Caitong International Asset Management first reported a position in NUVB in Q1 2025 and has held it in 5 quarters since. The position peaked at $148K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Caitong International Asset Management held 932 shares of Nuvation Bio worth $4K as of Q1 2026.
  • Caitong International Asset Management sold 14,105 Nuvation Bio shares in Q1 2026, an estimated $78.6K.
  • Nuvation Bio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1159 holding.
  • Caitong International Asset Management first reported a position in Nuvation Bio in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Nuvation Bio position peaked at $148K in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.